Expression of Fas (CD95) and FasL (CD95L) in human airway epithelium

American Journal of Respiratory Cell and Molecular Biology

Volumn 19, Issue 4, 1998, Pages 537-542

  Hamann, Kimm J ^a   Dorscheid, Delbert R ^b   Ko, Franklin D ^b   Conforti, Amber E ^b   Sperling, Anne I ^b   Rabe, Klaus F ^b   White, Steven R ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; FASLG PROTEIN, HUMAN; MEMBRANE PROTEIN; MESSENGER RNA;

APOPTOSIS; ARTICLE; BRONCHUS; CELL CULTURE; CHEMISTRY; CYTOLOGY; EPITHELIUM CELL; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; IMMUNOLOGY; PHYSIOLOGY; PNEUMONIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANTIGENS, CD95; APOPTOSIS; BLOTTING, WESTERN; BRONCHI; CELLS, CULTURED; EPITHELIAL CELLS; FAS LIGAND PROTEIN; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; MEMBRANE GLYCOPROTEINS; PNEUMONIA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0032185238     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.19.4.3100     Document Type: Article

References (30)

1. Yonehara, S., A. Ishii, and M. Yonehara. 1989. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169:1747-1756.
2. Trauth, B. C., C. Klas, A. M. J. Peters, S. Matzku, P. Moller, W. Falk, K.-M. Debatin, and P. M. Krammer. 1489. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301-305.
3. Nagafuji, K., T. Shibuya, M. Harada, S.-I. Mizuno, K. Takenaka, T. Miyamoto, T. Okumura, H. Gondo, and Y. Niho. 1995. Functional expression of Fas (CD95) on hematopoietic progenitor cells. Blood 86:883-889.
4. Nagata, S., and P. Goldstein. 1995. The Fas death factor. Science 267:1449-1456.
5. Lynch, D. H., F. Ramsdell, and M. R. Alderson. 1995. Fas and FasL in the homeostatic regulation of immune responses. Immunol. Today 16:569-574.
6. Hebestreit, H., S. Yousefi, I. Balatti, M. Weber, R. Crameri, D. Simon, K. Hartung, A. Schapowul, K. Blaser, and H.-U. Simon. 1996. Expression and function of the Fas receptor on human blood and tissue eosinophils. Eur. J. Immunol. 26:1775-1780.
7. Matsumoto, K., R. P. Schleimer, H. Saito, Y. Iikura, and B. S. Bochner, 1995. Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. Blood 86:1437-1443.
8. Druilhe, A., Z., Cai, S. Haile, S. Chouaib, and M. Pretolani. 1996. Fas-mediated apoptosis in cultured human eosinophils. Blood 87:2822-2830.
9. Liles, W. C., P. A. Kiener, J. A. Ledbetter, A. Aruffo, and S. J. Klebanoff, 1996. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J. Exp. Med. 184:429-440.
10. Gruenert, D. C., W. E. Finkbeiner, and J. H. Widdicombe, 1995. Culture and transformation of human airway epithelial cells. Am. J. Physiol. 268(Lung Cell Mol. Physiol.):L347-L360.
11. Cozens, A. L., M. J. Yezzi, K. Kunzelman, T. Ohrui, L. Chin, K. Eng, W. E. Finkbeiner, J. H. Widdicomhe, and D. C. Gruenert. 1994. CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 10:38-47.
12. Montel, A. H., M. R. Bochan, W. S. Goebel, and Z. Brahmi. 1995. Fas-mediated cytotoxicity remains intact in perform and granzyme B antisense transfectants of a human NK-like cell line. Cell Immunol. 165:312-317.
13. Cohen, P. L., and R. A. Eisenberg. 1995. Fas/Apo-1: a cell surface receptor that signals apoptosis. In Apoptosis and the Immune Response. C. D. Gregory, editor. Wiley-Liss, New York. 169-186.
14. Walker, P. R., P. Saas, and P.-Y. Dietrich. 1997. Role of Fas ligand (CD95L) in immune escape: the tumor cell strikes back. J. Immunol. 158:4521-1524.
15. Wilson, S. E., O. Li, J. Weng, P. A. Barry-Lane, J. V. Jester, Q. Liang, and R. J. Wordinger. 1996. The Fas-Fas ligand system and other modulators of apoptosis in the cornea. Invest Ophthalmol. Vis. Sci. 37:1582-1592.
16. Moller, P., H. Walczak, S. Riedl, J. Strater, and P. H. Krammer. 1996. Paneth cells express high levels of CD95 ligand transcripts. Am. J. Pathol. 149:9-13.
17. Iwamoto, M., T. Koji, N. Makiyama, and P. K. Nakane. 1996. Apoptosis of crypt epithelial cells in ulcerative colitis. J. Pathol. 180:152-159.
18. Liles, W. C., P. A. Kiener, J. A. Ledbetter, A. Aruffo, and J. Klebanoff. 1996. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J. Exp. Med. 184:429-440.
19. French, L. E., M. Hahne, I. Viard, G. Radlgruber, R. Zanone, K. Becker, C. Muller, and J. Tschopp. 1996. Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J. Cell Biol. 133:335-343.
20. Demoly, P., J. Simony-Lafontaine, P. Chanez, J.-L. Pujol, N. Lequeux, F.-B. Michel, and J. Bousquet. 1994. Cell proliferation in the bronchial mucosa of asthmatics and chronic bronchitics. Am J. Respir. Crit. Care Med. 150: 214-217.
21. Vaux, D. L., and A. Strasser. 1996. The molecular biology of apoptosis. Proc. Natl. Acad. Sci. USA 93:2239-2244.
22. Stanger, B. Z. 1996. Looking beneath the surface: the cell death pathway of Fas/APO-1 (CD95). Molec. Med. 2:7-20.
23. Mariana, S. M., B. Matiba, C. Baumler, and P. H. Krammer. 1995. Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases. Eur. J. Immunol 25:2303-2307.
24. Giordano, C., G. Stassi, R. DeMaria, M. Todaro, P. Richiusa, G. Papoff, G. Ruberti, M. Bagnasco, R. Testi, and A. Galluzo. 1997. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275:960-963.
25. French, L. E., and J. Tschopp. 1996. Constitutive Fas ligand expression in several non-lymphoid mouse tissues: implications for immune-protection and cell turnover. Behring Inst. Mitt. 97:156-160.
26. Bellgrau, D., D. Gold, H. Selawry, J. Moore, A. Franzusoff, and R. C. Duke. 1995. A role for CD95 ligand in preventing graft rejection. Nature 377:630-632.
27. Weller, M., and A. Fontana. 1995. The failure of current immunotherapy for malignant glioma. Brain Res. Rev. 21:128-151.
28. Hunt, J. S., D. Vassmer, T. A. Ferguson, and L. Miller. 1997. Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus. J. Immunol. 158:4122-4128.
29. Kayagaki, N., N. Yamaguchi, F. Nagao, S. Matsuo, H. Maeda, K. Okumura, and H. Yagita. 1997. Polymorphism of murine Fas ligand that affects the biological activity. Proc. Natl. Acad. Sci. USA 94:3914-3919.
30. Niehans, G. A., T. Brunner, S. P. Freizelle, J. C. Liston, C. T. Salerno, D. J. Knapp, D. R. Green, and R. A. Kratzke. 1997. Human lung carcinomas express Fas ligand. Cancer Res. 57:1007-1012.